Evaluate the Efficacy and Safety of DWJ211 in Patient With Moderate or Severe Submental Fat

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2019
DWJ211 is a injectable drug for improvement in the appearance of moderate to severe submental fat (SMF)
Epistemonikos ID: 7fbad78dc9c7a8d9ff8be44cfa84aa7910c65d00
First added on: May 22, 2024